{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:59:05Z","timestamp":1778687945820,"version":"3.51.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1124\/jpet.116.235630","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T03:40:25Z","timestamp":1480563625000},"page":"280-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Behavioral Characterization of \u03ba Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats"],"prefix":"10.1016","volume":"360","author":[{"given":"Vanessa","family":"Minervini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.235630_bib1","series-title":"Opioids II","first-page":"205","article-title":"Physiological function of opioid: temperature regulation","author":"Adler","year":"1993"},{"key":"10.1124\/jpet.116.235630_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1124\/jpet.102.037655","article-title":"Functional effects of systemically administered agonists and antagonists of mu, \u03b4, and kappa opioid receptor subtypes on body temperature in mice","volume":"302","author":"Baker","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-001-0949-2","article-title":"Sex and rat strain determine sensitivity to kappa opioid-induced antinociception","volume":"160","author":"Barrett","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.116.235630_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/00000542-200106000-00018","article-title":"Analgesic and antiinflammatory effects of two novel kappa-opioid peptides","volume":"94","author":"Binder","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.116.235630_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(25)12955-8","article-title":"Discriminative stimulus effects on enadoline in pigeons","volume":"277","author":"Brandt","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0091-3057(98)00017-3","article-title":"Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats","volume":"60","author":"Briggs","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.235630_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0143-4179(89)90033-4","article-title":"Hypothermia elicited by some prodynorphin-derived peptides: opioid and non-opioid actions","volume":"14","author":"Cavicchini","year":"1989","journal-title":"Neuropeptides"},{"key":"10.1124\/jpet.116.235630_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1208\/s12248-011-9296-3","article-title":"Quantitative PK-PD model-based translational pharmacology of a novel kappa opioid receptor antagonist between rats and humans","volume":"13","author":"Chang","year":"2011","journal-title":"AAPS J"},{"key":"10.1124\/jpet.116.235630_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/npp.2010.137","article-title":"The therapeutic potential of \u03ba-opioids for treatment of pain and addiction","volume":"36","author":"Chavkin","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.235630_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2013.09.053","article-title":"Diuretic effects of cannabinoid agonists in mice","volume":"721","author":"Chopda","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00008877-200402000-00002","article-title":"Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm","volume":"15","author":"De Vry","year":"2004","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/mol.115.098483","article-title":"CB1 knockout mice unveil sustained CB2-mediated antiallodynic effects of the mixed CB1\/CB2 agonist CP55,940 in a mouse model of paclitaxel-induced neuropathic pain","volume":"88","author":"Deng","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(93)90224-D","article-title":"Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain","volume":"53","author":"Desmeules","year":"1993","journal-title":"Pain"},{"key":"10.1124\/jpet.116.235630_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-3565(25)39097-X","article-title":"Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects","volume":"242","author":"Dykstra","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib57","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jpain.2012.03.009","article-title":"The economic cost of pain in the United States","volume":"13","author":"Gaskin","year":"2012","journal-title":"J Pain"},{"key":"10.1124\/jpet.116.235630_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/jpet.115.231381","article-title":"Combined treatment with morphine and \u03949-tetrahydrocannabinol in rhesus monkeys: antinociceptive tolerance and withdrawal","volume":"357","author":"Gerak","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib17","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","article-title":"Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors","volume":"22","author":"Ghozland","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.116.235630_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1124\/jpet.104.067264","article-title":"Isobolographic analysis for combinations of a full and partial agonist: curved isoboles","volume":"310","author":"Grabovsky","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2006.11.062","article-title":"Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia","volume":"558","author":"Hamamoto","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.2042-7158.1985.tb04985.x","article-title":"Effect of beta-funaltrexamine on opioid side-effects produced by morphine and U-50, 488H","volume":"37","author":"Hayes","year":"1985","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00213-010-1819-6","article-title":"Kappa opioids and the modulation of pain","volume":"210","author":"Kivell","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.116.235630_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fpsyt.2014.00170","article-title":"The kappa opioid receptor: from addiction to depression, and back","volume":"5","author":"Lalanne","year":"2014","journal-title":"Front Psychiatry"},{"key":"10.1124\/jpet.116.235630_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3565(25)22031-6","article-title":"Further study of kappa opioids on increased urination","volume":"227","author":"Leander","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/FBP.0000000000000184","article-title":"Additive antinociceptive effects of mixtures of the \u03ba-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats","volume":"27","author":"Maguire","year":"2016","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.113.204099","article-title":"Interactions between \u03bc-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration","volume":"345","author":"Maguire","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib26","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(95)02066-7","article-title":"Aversive effects of the synthetic cannabinoid CP 55,940 in rats","volume":"53","author":"McGregor","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.235630_bib58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3565(24)37657-8","article-title":"Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys","volume":"286","author":"Mellow","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0091-3057(01)00537-8","article-title":"Potentiation of kappa-opioid receptor agonist-induced analgesia and hypothermia by fluoxetine","volume":"69","author":"Nemmani","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.235630_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/FBP.0b013e32835a7c4d","article-title":"\u0394(9)-Tetrahydrocannabinol acts as a partial agonist\/antagonist in mice","volume":"23","author":"Paronis","year":"2012","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/jpet.112.199331","article-title":"Diuretic effects of cannabinoids","volume":"344","author":"Paronis","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1476-5381.2008.00048.x","article-title":"Emerging strategies for exploiting cannabinoid receptor agonists as medicines","volume":"156","author":"Pertwee","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3565(25)22683-0","article-title":"Diuretic actions in man of a selective kappa opioid agonist: U-62,066E","volume":"240","author":"Peters","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib32","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1124\/jpet.116.235630_bib33","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3565(24)36640-6","article-title":"Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord","volume":"281","author":"Pugh","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib34","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3565(25)21168-5","article-title":"The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord","volume":"279","author":"Pugh","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","article-title":"Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside","volume":"6","author":"Rahn","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.116.235630_bib60","first-page":"822","article-title":"Effects of opioids, cannabinoids, and vanilloids on body temperature","volume":"3","author":"Rawls","year":"2011","journal-title":"Fron Biosci"},{"key":"10.1124\/jpet.116.235630_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1370\/afm.1421","article-title":"Opioids for chronic pain: first do no harm","volume":"10","author":"Rosenblatt","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1124\/jpet.116.235630_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(87)91571-X","article-title":"Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists","volume":"436","author":"Shippenberg","year":"1987","journal-title":"Brain Res"},{"key":"10.1124\/jpet.116.235630_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0304-3959(88)90225-4","article-title":"Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists","volume":"35","author":"Shippenberg","year":"1988","journal-title":"Pain"},{"key":"10.1124\/jpet.116.235630_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0091-3057(03)00189-8","article-title":"Social and environmental enrichment enhances sensitivity to the effects of kappa opioids: studies on antinociception, diuresis and conditioned place preference","volume":"76","author":"Smith","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.116.235630_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.physbeh.2008.03.015","article-title":"Effects of environmental enrichment on sensitivity to mu, kappa, and mixed-action opioids in female rats","volume":"94","author":"Smith","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.116.235630_bib42","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0022-3565(25)38633-7","article-title":"Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice","volume":"268","author":"Smith","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mayocp.2012.08.020","article-title":"Why patients visit their doctors: assessing the most prevalent conditions in a defined American population","volume":"88","author":"St Sauver","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1124\/jpet.116.235630_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.235630_bib45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1124\/jpet.116.235630_bib46","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/npp.2013.76","article-title":"Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion","volume":"38","author":"Tejeda","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.116.235630_bib47","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00008877-200302000-00008","article-title":"Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay","volume":"14","author":"Terner","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0014-2999(01)01267-5","article-title":"Sex differences in antinociceptive and motoric effects of cannabinoids","volume":"430","author":"Tseng","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.116.235630_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict Biol"},{"key":"10.1124\/jpet.116.235630_bib49","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies: tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.235630_bib50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist","volume":"9","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.116.235630_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.116.235630_bib52","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1503\/cmaj.071178","article-title":"Adverse effects of medical cannabinoids: a systematic review","volume":"178","author":"Wang","year":"2008","journal-title":"CMAJ"},{"key":"10.1124\/jpet.116.235630_bib53","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13181-012-0263-x","article-title":"Likeability and abuse liability of commonly prescribed opioids","volume":"8","author":"Wightman","year":"2012","journal-title":"J Med Toxicol"},{"key":"10.1124\/jpet.116.235630_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0376-8716(87)90004-4","article-title":"Behavioral characterization of opioid mixed agonist-antagonists","volume":"20","author":"Woods","year":"1987","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.116.235630_bib55","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00213-004-2087-0","article-title":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","volume":"179","author":"Zhang","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.116.235630_bib56","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1523\/JNEUROSCI.21-23-09499.2001","article-title":"Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice","volume":"21","author":"Zimmer","year":"2001","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.235630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:51:27Z","timestamp":1739994687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524194931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0022356524194931"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.235630","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral Characterization of \u03ba Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.235630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}